Clinical Trials Browser

Phase 1 × Myasthenia Gravis × Classical hematology × Clear all

NCT06978738 2025-05-18

UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases

Immunoglobulin G4-Related Disease, Anemia, Hemolytic, Autoimmune, Lupus Erythematosus, Systemic, Myasthenia Gravis, Myositis, Scleroderma, Systemic, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis